Profound Medical Corp.
Ticker: 1628808
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|
| INCOME | |||||
| Revenue | 2.48-53.6% | 5.34+5.5% | 5.06+155.6% | 1.98-15.4% | 2.34 |
| Total Income | 2.48-53.6% | 5.34+5.5% | 5.06+155.6% | 1.98-15.4% | 2.34 |
| EXPENSES | |||||
| Expenditure | 13.55+1.4% | 13.36-4.4% | 13.97-11.5% | 15.79+16.9% | 13.51 |
| Tax | 0.06+100.0% | 0.03-75.0% | 0.12+100.0% | 0.06+50.0% | 0.04 |
| PROFIT | |||||
| PBT | -9.49-35.0% | -7.03+10.6% | -7.86+49.7% | -15.63-46.3% | -10.68 |
| Net Profit | -9.54-35.3% | -7.05+11.7% | -7.98+49.2% | -15.70-46.5% | -10.72 |
| KEY METRICS | |||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.26-236.8% | 0.19-26.9% | 0.26-50.0% | 0.52+44.4% | 0.36 |
Corporate Events
Board MeetingPROF
20261Sep
Board Meeting
Richard R. Fabian appointed as President, succeeding Mathieu…
SEC Filing ↗ Board MeetingPROF
202614Aug
Board Meeting
Matthew Sobczyk appointed Interim Chief Financial Officer; R…
SEC Filing ↗ Board MeetingPROF
202613May
Board Meeting
Shareholders voted on the election of eight director nominee…
SEC Filing ↗